Monoclonal gammopathies of clinical significance: a critical appraisal
R Ríos-Tamayo, B Paiva, JJ Lahuerta, JM López… - Cancers, 2022 - mdpi.com
Simple Summary Monoclonal gammopathy of clinical significance (MGCS) refers to a
recently coined term describing a complex and heterogeneous group of nonmalignant …
recently coined term describing a complex and heterogeneous group of nonmalignant …
Increased COVID-19 breakthrough infection risk in patients with plasma cell disorders
J La, JTY Wu, W Branch-Elliman… - Blood, The Journal …, 2022 - ashpublications.org
COI notes: Dr Branch-Elliman reported receiving grants (site PI for multicenter study) from
Gilead Sciences and funds to institution and grants from VA Health Services Research and …
Gilead Sciences and funds to institution and grants from VA Health Services Research and …
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance
Two Letters to Blood address the risks of COVID-19 in populations with precursors of
hematological disease. In the first article, Miller and colleagues report on whether clonal …
hematological disease. In the first article, Miller and colleagues report on whether clonal …
SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance
N Sgherza, D Di Gennaro, P Curci, R Rizzi… - …, 2022 - journals.lww.com
Epidemiological studies have previously reported that patients with monoclonal
gammopathy of undetermined significance (MGUS) may have an increased risk of …
gammopathy of undetermined significance (MGUS) may have an increased risk of …
Risk and severity of COVID-19 infection in monoclonal gammopathy of undetermined significance: a 3-year propensity matched cohort study
OS Ashruf, Z Orozco, DC Kaelber - Clinical Lymphoma Myeloma and …, 2023 - Elsevier
Introduction Monoclonal gammopathy of undetermined significance (MGUS) is a
premalignant disorder causing monoclonal plasma cell proliferation in bone marrow. This …
premalignant disorder causing monoclonal plasma cell proliferation in bone marrow. This …
[HTML][HTML] Humoral immune response after anti-SARS-CoV-2 vaccine “Booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)
N Sgherza, P Curci, R Rizzi, AMV Larocca… - … of Hematology and …, 2023 - ncbi.nlm.nih.gov
To the editor. Monoclonal gammopathy of undetermined significance (MGUS) is a pre-
malignant plasma cell disorder reported in approximately 3-4% of individuals aged> 50 …
malignant plasma cell disorder reported in approximately 3-4% of individuals aged> 50 …
[PDF][PDF] Monoclonal Gammopathies of Clinical Significance: A Critical Appraisal. Cancers 2022, 14, 5247
R Ríos-Tamayo, B Paiva, JJ Lahuerta, JM López… - 2022 - docta.ucm.es
Monoclonal gammopathies of clinical significance (MGCSs) represent a group of diseases
featuring the association of a nonmalignant B cells or plasma cells clone, the production of …
featuring the association of a nonmalignant B cells or plasma cells clone, the production of …
Blóðkalsíumhækkun í fólki með góðkynja einstofna mótefnahækkun
ÁH Jónsdóttir - skemman.is
Blóðkalsíumhækkun er eitt af greiningarskilmerkjum mergæxlis og því er kalsíum mælt
reglulega í einstaklingum með góðkynja einstofna mótefnahækkun (e. monoclonal …
reglulega í einstaklingum með góðkynja einstofna mótefnahækkun (e. monoclonal …